Macquarie initiated coverage of Addus HomeCare with an Outperform rating and $136 price target. Addus is a leading home and community-based service provider with a track record of consistent earnings growth and prudent capital management, the analyst tells investors in a research note. The firm says scaling personal-care services and overlaying home health and hospice positions the company well for value-based care contracting.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADUS:
- Addus HomeCare 1.5M share Spot Secondary priced at $108.00
- Addus HomeCare 1.5M share Spot Secondary; price range $108.00-$111.00
- Addus HomeCare announces offering of 1.5M shares of common stock
- Addus HomeCare price target raised to $128 from $119 at TD Cowen
- Addus HomeCare price target raised to $135 from $127 at BofA